Corsicana & Co’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Sell
100
-100
-50% -$18.8K 0.01% 196
2026
Q1
$14.7K Buy
200
+100
+100% +$19.3K 0.01% 170
2025
Q4
$18.4K Hold
100
0.01% 168
2025
Q3
$15.3K Buy
+100
New +$15.1K 0.01% 172
2022
Q3
$11K Hold
100
0.01% 168
2022
Q2
$13K Sell
100
-150
-60% -$19.7K 0.01% 171
2022
Q1
$33K Hold
250
0.02% 154
2021
Q4
$29K Hold
250
0.02% 153
2021
Q3
$30K Hold
250
0.02% 149
2021
Q2
$30K Buy
+250
New +$27.4K 0.02% 147

Other funds holding AZN

Corsicana & Co's AZN Position: Q2 2026 in Review

Corsicana & Co reduced its AstraZeneca (AZN) stake by 50% in Q2 2026, selling an estimated $18.8K and leaving 100 shares worth $18.7K. The position accounts for 0.01% of the portfolio, ranked #196.

Corsicana & Co first reported a position in AZN in Q2 2021 and has held it in 10 quarters since. The position peaked at $33K in Q1 2022. 742 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Corsicana & Co held 100 shares of AstraZeneca worth $18.7K as of Q2 2026.
  • Corsicana & Co sold 100 AstraZeneca shares in Q2 2026, an estimated $18.8K.
  • AstraZeneca made up 0.01% of Corsicana & Co's portfolio in Q2 2026, its #196 holding.
  • Corsicana & Co first reported a position in AstraZeneca in Q2 2021 and has held it in 10 quarters since.
  • Corsicana & Co's AstraZeneca position peaked at $33K in Q1 2022.
  • 742 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.